Review

Detection of Endocrine Disrupting Drugs with Quantum Dot Molecularly Imprinted Polymer

Volume: 45 Number: 2 June 1, 2025
EN

Detection of Endocrine Disrupting Drugs with Quantum Dot Molecularly Imprinted Polymer

Abstract

Endocrine disrupting chemicals are causing serious harm to health and increasing the disease burden worldwide and pose a global health risk by disrupting the endocrine system through various biological pathways. The combination of MIPs and QDs offers high sensitivity fluorescence analysis and holds promise for detection at very low concentrations. In recent years, quantum dots have found significant application in biomedical applications such as biosensors and clinical diagnosis due to their traceable optical properties. QDs have unique optical advantages such as high luminescence intensity, high molar extinction coefficient and customizable emission properties depending on their size. With the help of MIPs, QDs specifically recognize target analytes, interact with the fluorescent signal source and thus changes in the fluorescence intensity of the target analyte can be monitored. The presence of endocrine disrupting drugs in water, biological fluids, animal feed and meat samples is known as a result of studies. Considering the difficulty and durability of biodegradation of these drugs, their detection by QD/MIPs is of great importance. This review summarizes recent work on the development of fluorescent QD/MIP sensors for the detection of endocrine disrupting drugs.

Keywords

References

  1. 1. Son E, Kwon KH. How body burden from exposure to endocrine disruptors effects accelerated aging?. Environ Res Tec. 2023;6(4):383-390. https://doi.org/10.35208/ert.1334434
  2. 2. Sabir S, Akhtar MF, Saleem A. Endocrine disruption as an adverse effect of non-endocrine targeting pharmaceuticals. Envıron Scı Pollut R. 2019;26:1277–1286. https://doi.org/10.1007/s11356-018-3774-4
  3. 3. Mostafalou S, Abdollahi M. Pesticides and human chronic diseases: evidences, mechanisms and perspectives. Toxicol Appl Pharm. 2013;268(2):157–177. https://doi.org/10.1016/j.taap.2013.01.025
  4. 4. Perng W, Cantoral A, Soria-Contreras D, Betanzos-Robledo L, Kordas K, Liu Y, et al. Exposure to obesogenic endocrine disrupting chemicals and obesity among youth of Latino or Hispanic origin in the United States and Latin America: A lifecourse perspective. Obes. Rev. 2021;22(S3). https://doi.org/10.1111/obr.13245
  5. 5. Güntürk A. Güncel Obezojenler. In: Kadiroğlu A.K, editor. Güncel Genel Dahiliye Çalışmaları. Chapter 4. 2022. p. 35-47.
  6. 6. Rato L, Sousa AC. The impact of endocrine-disrupting chemicals in male fertility: focus on the action of obesogens. J. Xenobiotics, 2021;11(4):163-196. https://doi.org/10.3390/jox11040012
  7. 7. Mascarenhas C, Sousa ACA, Rato L. Effects of Pharmaceutical Substances with Obesogenic Activity on Male Reproducti-ve Health. Int. J. Mol. Sci. Int. J. Mol. Sci. 2024; 25(4). https://doi.org/10.3390/ijms25042324
  8. 8. Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. New Eng. J. Med. 2006;355:2427–2443. doi: 10.1056/NEJMoa066224

Details

Primary Language

English

Subjects

Pharmaceutical Analytical Chemistry

Journal Section

Review

Publication Date

June 1, 2025

Submission Date

February 13, 2025

Acceptance Date

May 13, 2025

Published in Issue

Year 2025 Volume: 45 Number: 2

APA
Ozturk, D., Gökdere, N., & Palabıyık, İ. M. (2025). Detection of Endocrine Disrupting Drugs with Quantum Dot Molecularly Imprinted Polymer. Hacettepe University Journal of the Faculty of Pharmacy, 45(2), 175-187. https://doi.org/10.52794/hujpharm.1639507
AMA
1.Ozturk D, Gökdere N, Palabıyık İM. Detection of Endocrine Disrupting Drugs with Quantum Dot Molecularly Imprinted Polymer. HUJPHARM. 2025;45(2):175-187. doi:10.52794/hujpharm.1639507
Chicago
Ozturk, Durdane, Nuran Gökdere, and İsmail Murat Palabıyık. 2025. “Detection of Endocrine Disrupting Drugs With Quantum Dot Molecularly Imprinted Polymer”. Hacettepe University Journal of the Faculty of Pharmacy 45 (2): 175-87. https://doi.org/10.52794/hujpharm.1639507.
EndNote
Ozturk D, Gökdere N, Palabıyık İM (June 1, 2025) Detection of Endocrine Disrupting Drugs with Quantum Dot Molecularly Imprinted Polymer. Hacettepe University Journal of the Faculty of Pharmacy 45 2 175–187.
IEEE
[1]D. Ozturk, N. Gökdere, and İ. M. Palabıyık, “Detection of Endocrine Disrupting Drugs with Quantum Dot Molecularly Imprinted Polymer”, HUJPHARM, vol. 45, no. 2, pp. 175–187, June 2025, doi: 10.52794/hujpharm.1639507.
ISNAD
Ozturk, Durdane - Gökdere, Nuran - Palabıyık, İsmail Murat. “Detection of Endocrine Disrupting Drugs With Quantum Dot Molecularly Imprinted Polymer”. Hacettepe University Journal of the Faculty of Pharmacy 45/2 (June 1, 2025): 175-187. https://doi.org/10.52794/hujpharm.1639507.
JAMA
1.Ozturk D, Gökdere N, Palabıyık İM. Detection of Endocrine Disrupting Drugs with Quantum Dot Molecularly Imprinted Polymer. HUJPHARM. 2025;45:175–187.
MLA
Ozturk, Durdane, et al. “Detection of Endocrine Disrupting Drugs With Quantum Dot Molecularly Imprinted Polymer”. Hacettepe University Journal of the Faculty of Pharmacy, vol. 45, no. 2, June 2025, pp. 175-87, doi:10.52794/hujpharm.1639507.
Vancouver
1.Durdane Ozturk, Nuran Gökdere, İsmail Murat Palabıyık. Detection of Endocrine Disrupting Drugs with Quantum Dot Molecularly Imprinted Polymer. HUJPHARM. 2025 Jun. 1;45(2):175-87. doi:10.52794/hujpharm.1639507